GBP/USD 1.354 EUR/GBP 0.862 GBP/JPY 199.878 EUR/USD 1.167 GBP/AUD 2.080 USD/JPY 147.638 USD/CAD 1.378 AUD/USD 0.651 CAD/JPY 107.104 EUR/CAD 1.609 GBP/CAD 1.866 AUD/CAD 0.897 AUD/JPY 96.106 AUD/NZD 1.097 EUR/AUD 1.793 GBP/USD 1.354 EUR/GBP 0.862 GBP/JPY 199.878 EUR/USD 1.167 GBP/AUD 2.080 USD/JPY 147.638 USD/CAD 1.378 AUD/USD 0.651 CAD/JPY 107.104 EUR/CAD 1.609 GBP/CAD 1.866 AUD/CAD 0.897 AUD/JPY 96.106 AUD/NZD 1.097 EUR/AUD 1.793
CURRENCY .wiki

Finance News – Mounjaro

What is your interest today?

The Guardian – Business • Aug 14, 2025

Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands

Eli Lilly’s planned increase in the UK cost for its obesity medication reflects a strategic adjustment influenced by US political pressure, potentially affecting affordability and...

Read Full Article →
Euronews Business • Aug 14, 2025

Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro by up to 170%

The substantial increase in the cost of Mounjaro reflects a strategic pricing adjustment by Eli Lilly, which may influence overall expenditure within the UK pharmaceutical market d...

Read Full Article →
Financial Times • Aug 14, 2025

Eli Lilly raises UK price of weight-loss drug Mounjaro by up to 170%

Eli Lilly has significantly increased the cost of its weight-loss medication in the UK, reflecting broader concerns about pricing disparities between countries and the financial bu...

Read Full Article →
MarketWatch Top Stories • Aug 02, 2025

Weight-loss drugs may be covered by Medicare, Medicaid under experimental program

The experimental program could potentially reduce out-of-pocket expenses for patients by allowing Medicare and Medicaid to cover expensive GLP-1 medications used for weight managem...

Read Full Article →
CNBC Business • May 01, 2025

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...

Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...

Read Full Article →